These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9871605)

  • 21. Novel antagonists of the inhibitory glycine receptor derived from quinolinic acid compounds.
    Schmieden V; Jezequel S; Betz H
    Mol Pharmacol; 1996 Nov; 50(5):1200-6. PubMed ID: 8913351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: in vivo active AMPA and NMDA(glycine) antagonists.
    Auberson YP; Acklin P; Bischoff S; Moretti R; Ofner S; Schmutz M; Veenstra SJ
    Bioorg Med Chem Lett; 1999 Jan; 9(2):249-54. PubMed ID: 10021939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
    Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors.
    Ametamey SM; Kokic M; Carrey-Rémy N; Bläuenstein P; Willmann M; Bischoff S; Schmutz M; Schubiger PA; Auberson YP
    Bioorg Med Chem Lett; 2000 Jan; 10(1):75-8. PubMed ID: 10636248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones: excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity.
    Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
    J Med Chem; 1999 Jul; 42(13):2478-84. PubMed ID: 10395489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN; Stephens DN
    J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of NMDA receptor glycine recognition site antagonism: dependence on glycine concentration.
    Pearlstein RD; Beirne JP; Massey GW; Warner DS
    J Neurochem; 1998 May; 70(5):2012-9. PubMed ID: 9572287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACEA 1021: flip or flop?
    Petty MA; Weintraub PM; Maynard KI
    CNS Drug Rev; 2004; 10(4):337-48. PubMed ID: 15592582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CoMFA and homology-based models of the glycine binding site of N-methyl-d-aspartate receptor.
    Tikhonova IG; Baskin II; Palyulin VA; Zefirov NS
    J Med Chem; 2003 Apr; 46(9):1609-16. PubMed ID: 12699379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of NMDA receptor antagonists on nociceptive responses in vivo: comparison of antagonists acting at the glycine site with uncompetitive antagonists.
    McClean M; Chizh BA; Headley PM
    Amino Acids; 1998; 14(1-3):217-21. PubMed ID: 9871464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and of their constrained analogue imidazo.
    Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
    Eur J Med Chem; 2001 Feb; 36(2):203-9. PubMed ID: 11311751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
    Nishiyama T
    Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity.
    Jimonet P; Ribeill Y; Bohme GA; Boireau A; Chevé M; Damour D; Doble A; Genevois-Borella A; Herman F; Imperato A; Le Guern S; Manfré F; Pratt J; Randle JC; Stutzmann JM; Mignani S
    J Med Chem; 2000 Jun; 43(12):2371-81. PubMed ID: 10882363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor.
    Lingenhöhl K; Pozza MF
    Neuropharmacology; 1998 Jun; 37(6):729-37. PubMed ID: 9707286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds.
    Cai SX
    Curr Top Med Chem; 2006; 6(7):651-62. PubMed ID: 16719807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.